Ads
related to: zepboundro.co has been visited by 100K+ users in the past month
reflexmd.com has been visited by 10K+ users in the past month
Search results
1 Disruptive Biotech Stock to Buy Now, and 1 to Consider | The Motley Fool
The Motley Fool· 17 hours agoTo accomplish that, it'll need to survive long enough to advance its flagship program, VK2735, through its remaining late-stage clinical trials. As the company doesn't yet have any medicines ...
Structure Therapeutics Stock Soars on Obesity Pill Data
The Wall Street Journal· 16 hours agoShares of Structure Therapeutics jumped more than 45% Monday after a new clinical study boosted...
Aristocrats in Disguise: 3 Blue-Chip Stocks With Stealth Growth Potential Aristocrats in Disguise: 3...
InvestorPlace· 4 days agoAlthough there is no hard-and-fast rule about what constitutes a blue-chip stock, they all tend to...
Him & Hers Director Bought Stock After Weight-Loss Surge
Barrons.com· 4 days agoChristopher Payne paid $2 million for shares of health platform Hims & Hers, which said it will...
This Is the Biggest Risk for Eli Lilly and Novo Nordisk Investors
Motley Fool via Yahoo Finance· 3 days agoHow they got here is no mystery; they both possess some exciting glucagon-like peptide 1 (GLP-1)...
Weight loss drugs are so hard to find that this company built a tracker
Axios· 5 days agoPatients struggling to find doses of blockbuster anti-obesity and diabetes drugs will have new help...
Millions of Americans need drugs like Ozempic. Will it bankrupt the healthcare system?
Los Angeles Times· 6 days ago“As important as these drugs are, they will not do any good for the millions of patients who cannot...
Prediction: These Could Be the Best-Performing Pharmaceutical Stocks Through 2030
Motley Fool via Yahoo Finance· 2 days agoIn the first quarter, Ozempic generated revenue of 27.8 billion Danish kroner, or DKK ($4 billion),...
Structure's obesity pill surpasses expectations in mid-stage study
Reuters via AOL· 19 hours agoThe California-based drug developer is vying for a share of the global obesity treatment market that is estimated to be worth about $150 billion by the early 2030s. The current market leaders ...
Ozempic-Like Drugs Could Lower Sales of Junk Food - Slashdot
Slashdot· 1 day agoWill appetite-suppressing drugs hurt the sugar industry? Executives from Walmart warned that Ozempic and Zepbound "are impacting food sales," reports Bloomberg, "and multiple ...
Ads
related to: zepboundro.co has been visited by 100K+ users in the past month
reflexmd.com has been visited by 10K+ users in the past month